FOCUS Immunology Laboratory Heidelberg (GLP-certified)
Fully equipped tissue culture facility, flow cytometry,
multiformat reader, PCR
Cytokine Release Assays for Safety Assessment of Biologicals
Immunogenicity testing
Functional testing of immune cells for mode-of-action analysis
Immune-monitoring of clinical trials
PK/PD assessment for Biologicals/Biosimilars
Cytokine Release Assays for Safety Assessment of Biologicals
- Combination of cell culture, stimulation and cytokine detection
- Stimulation of whole blood or defined cellular subpopulations
- Protocols consider post TGN 1412 requirements
Immunogenicity Testing According to EMA Guidelines
- Assay development, validation and GLP-compliant performance
- Screening assays
- Confirmatory assays
- Assays for neutralizing antibodies
- Various ELISA formats available: Bridging, direct, competitive
- Cellular immunity assessment
Cell-based Functional Assays
Proliferation
- Metabolic (ATP) assay via luminescence
- CFSE and BrdU assay via fluorescence
Intracellular Cytokine Staining (ICS)
- Multi-parametric analysis for detection of multiple cytokine producing cells
Apoptosis
- Caspase 3/7 induction
- Annexin V assay
- Cell Morphology
Cytotoxicity
- LDH release
- Protease release
NO-production
Histamine release
Innate immunity evaluation via stimulation of
Toll-like receptors (“TLR stimulation assays”)
Lymphocyte Stimulation Assays
Defined healthy blood donors under EC vote
Immune Cell Preparations
- Whole blood
- Peripheral Blood Mononuclear Cells (PBMC)
- Purified subpopulations
Antigen specific stimulations
- CMV-peptides
- PPD
- Tetanus Toxoid
- Influenza Peptides
Polyclonal stimulations
- Antibody-mediated, e. g. antiCD3/CD28
- Mitogens, e. g. PHA and LPS
- PMA and Ionomycin
- “Superantigens” e. g. SEB
Functional read-out after stimulation
- Proliferation
- Cytokine Release (ELISA, ELISPOT, ICS)
- Induction of apoptosis
- Cytotoxicity
Fully Equipped
- Tissue Culture
- Flow cytometry
- Mulitformat Reader
- PCR
Mediator/Cytokine Analysis “ready to go”:
Contact
| Dr. Eddy Bruyns Phone: +49 6221 64935-124 Fax: +49 6221 64935-110 eddy.bruyns@focus-cdd.com FOCUS CDD GmbH |
Dr. Karl Michaelis Phone: +49 731 9840-240 Fax: +49 7319840-324 karl.michaelis@nuvisan.de Nuvisan GmbH |
Full Service CRO
driven by Experience, Commitment, Technology
All Services under one roof
LAB Services
- Bioanalytics
- Pharmaceutical Analytics
- Clinical Trial Supplies
- Biopharmaceuticals
Focus Phase I
- Early Stage Clinical Development
- FIM/FIP/BE Studies
- Ethnicity Bridging Studies
Phase II – IV
- Oncology
- EDC Solutions
- Biostatistics
- Regulatory Affairs


Tuesday, April 19, 2011
0 Comments